Skip to main content
Erschienen in: Surgical Endoscopy 1/2014

01.01.2014

Response to glucose tolerance testing and solid high carbohydrate challenge: comparison between Roux-en-Y gastric bypass, vertical sleeve gastrectomy, and duodenal switch

verfasst von: Mitchell S. Roslin, Yuriy Dudiy, Andrew Brownlee, Joanne Weiskopf, Paresh Shah

Erschienen in: Surgical Endoscopy | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Hyperinsulinemic hypoglycemia is common after Roux-en-Y gastric bypass (RYGB) and may result in weight regain. The purpose of our investigation was to compare the effect of RYGB, vertical sleeve gastrectomy (VSG), and duodenal switch (DS) on insulin and glucose response to carbohydrate challenge.

Methods

Patients meeting National Institutes of Health criteria for bariatric surgery selected their bariatric procedure after evaluation and education in this prospective nonrandomized study. Preoperatively and at 6, 9, and 12 months’ follow-up, patients underwent blood draw to determine levels of fasting glucose, fasting insulin, glycated hemoglobin (HbA1c), C-peptide, and 2-h oral glucose challenge test. Homoeostatic Model Assessment (HOMA)-IR, fasting to 1-h and 1- to 2-h ratios of glucose and insulin, were calculated. Statistical analysis was performed using ANOVA and Student’s paired t test. All procedures were performed via a laparoscopic technique at a single institution.

Results

Data from a total of 38 patients (13 RYGB, 12 VSG, 13 DS) were available for analysis. At baseline, all groups were similar; the only statistically significant difference was that DS patients had a higher preoperative weight and body mass index (BMI). All operations caused weight loss (BMI 47.7 ± 10–30.7 ± 6.4 kg/m2 in RYGB; 45.7 ± 8.5–31.1 ± 5.5 kg/m2 in VSG; 55.9 ± 11.4–27.5 ± 5.6 kg/m2 in DS), reduction of fasting glucose, and improved insulin sensitivity. RYGB patients had a rapid rise in glucose with an accompanying rise in 1-h insulin to a level that exceeded preoperative levels. This was followed by a rapid decrease in glucose level. In comparison, DS patients had a lower increase in glucose and 1-h insulin, and the lowest HbA1c. These differences were statistically significant at various data points. For VSG, the results were intermediary.

Conclusions

Compared to gastric bypass, DS results in greater weight loss and improves insulin sensitivity and glucose homeostasis without causing a hyperinsulinemic response. Because the response to challenge after VSG is intermediary, pyloric preservation alone cannot account for this difference.
Literatur
1.
Zurück zum Zitat Sjostrom L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med 273(3):219–234PubMedCrossRef Sjostrom L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med 273(3):219–234PubMedCrossRef
2.
Zurück zum Zitat Cui Y, Elahi D, Andersen DK (2011) Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. J Gastrointest Surg 15(10):1879–1888PubMedCrossRef Cui Y, Elahi D, Andersen DK (2011) Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. J Gastrointest Surg 15(10):1879–1888PubMedCrossRef
3.
Zurück zum Zitat Rabiee A, Magruder JT, Salas-Carrillo R, Carlson O, Egan JM, Askin FB, Elahi D, Andersen DK (2011) Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. J Surg Res 167(2):199–205PubMedCentralPubMedCrossRef Rabiee A, Magruder JT, Salas-Carrillo R, Carlson O, Egan JM, Askin FB, Elahi D, Andersen DK (2011) Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. J Surg Res 167(2):199–205PubMedCentralPubMedCrossRef
4.
Zurück zum Zitat Roslin MS, Oren JH, Polan BN, Damani T, Brauner R, Shah PC (2013) Abnormal glucose tolerance testing after gastric bypass. Surg Obes Relat Dis 9(1):26–31PubMedCrossRef Roslin MS, Oren JH, Polan BN, Damani T, Brauner R, Shah PC (2013) Abnormal glucose tolerance testing after gastric bypass. Surg Obes Relat Dis 9(1):26–31PubMedCrossRef
5.
Zurück zum Zitat Mathavan VK, Arregui M, Davis C, Singh K, Patel A, Meacham J (2010) Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia. Surg Endosc 24(10):2547–2555PubMedCrossRef Mathavan VK, Arregui M, Davis C, Singh K, Patel A, Meacham J (2010) Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia. Surg Endosc 24(10):2547–2555PubMedCrossRef
6.
Zurück zum Zitat Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV (2005) Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353(3):249–254PubMedCrossRef Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV (2005) Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353(3):249–254PubMedCrossRef
7.
8.
Zurück zum Zitat Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97(3):505–516PubMedCrossRef Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97(3):505–516PubMedCrossRef
9.
Zurück zum Zitat Halperin F, Patti ME, Skow M, Bajwa M, Goldfine AB (2011) Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass. J Obes 2011:869536PubMedCentralPubMedCrossRef Halperin F, Patti ME, Skow M, Bajwa M, Goldfine AB (2011) Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass. J Obes 2011:869536PubMedCentralPubMedCrossRef
10.
Zurück zum Zitat Hedberg J, Sundbom M (2013) Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass—a randomized controlled trial. Surg Obes Relat Dis 8(3):338–343CrossRef Hedberg J, Sundbom M (2013) Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass—a randomized controlled trial. Surg Obes Relat Dis 8(3):338–343CrossRef
11.
Zurück zum Zitat Rawlins L, Rawlins MP, Brown CC, Schumacher DL (2013) Sleeve gastrectomy: 5-year outcomes of a single institution. Surg Obes Relat Dis 9(1):21–25PubMedCrossRef Rawlins L, Rawlins MP, Brown CC, Schumacher DL (2013) Sleeve gastrectomy: 5-year outcomes of a single institution. Surg Obes Relat Dis 9(1):21–25PubMedCrossRef
12.
Zurück zum Zitat Dorman RB, Rasmus NF, al-Haddad BJ, Serrot FJ, Slusarek BM, Sampson BK, Buchwald H, Leslie DB, Ikramuddin S (2012) Benefits and complications of the duodenal switch/biliopancreatic diversion compared to the Roux-en-Y gastric bypass. Surgery 152(4):758–765PubMedCrossRef Dorman RB, Rasmus NF, al-Haddad BJ, Serrot FJ, Slusarek BM, Sampson BK, Buchwald H, Leslie DB, Ikramuddin S (2012) Benefits and complications of the duodenal switch/biliopancreatic diversion compared to the Roux-en-Y gastric bypass. Surgery 152(4):758–765PubMedCrossRef
13.
Zurück zum Zitat Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G (2013) Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects. Ann Surg 257(3):462–468PubMedCrossRef Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G (2013) Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects. Ann Surg 257(3):462–468PubMedCrossRef
14.
Zurück zum Zitat McLaughlin T, Peck M, Holst J, Deacon C (2010) Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab 95(4):1851–1855PubMedCrossRef McLaughlin T, Peck M, Holst J, Deacon C (2010) Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab 95(4):1851–1855PubMedCrossRef
15.
Zurück zum Zitat Mallory GN, Macgregor AM, Rand CS (1996) The influence of dumping on weight loss after gastric restrictive surgery for morbid obesity. Obes Surg 6(6):474–478PubMedCrossRef Mallory GN, Macgregor AM, Rand CS (1996) The influence of dumping on weight loss after gastric restrictive surgery for morbid obesity. Obes Surg 6(6):474–478PubMedCrossRef
16.
Zurück zum Zitat Frenken M, Cho EY, Karcz WK, Grueneberger J, Kuesters S (2011) Improvement of type 2 diabetes mellitus in obese and non-obese patients after the duodenal switch operation. J Obes 2011:860169PubMedCentralPubMedCrossRef Frenken M, Cho EY, Karcz WK, Grueneberger J, Kuesters S (2011) Improvement of type 2 diabetes mellitus in obese and non-obese patients after the duodenal switch operation. J Obes 2011:860169PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366(17):1567–1576PubMedCentralPubMedCrossRef Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366(17):1567–1576PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Mingrone G, Castagneto-Gissey L (2009) Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 35(6 Pt 2):518–523PubMedCrossRef Mingrone G, Castagneto-Gissey L (2009) Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 35(6 Pt 2):518–523PubMedCrossRef
19.
20.
Zurück zum Zitat Johansson HE, Haenni A, Karlsson FA, Edén-Engström B, Ohrvall M, Sundbom M, Zethelius B (2010) Bileopancreatic diversion with duodenal switch lowers both early and late phases of glucose, insulin and proinsulin responses after meal. Obes Surg 20(5):549–558PubMedCrossRef Johansson HE, Haenni A, Karlsson FA, Edén-Engström B, Ohrvall M, Sundbom M, Zethelius B (2010) Bileopancreatic diversion with duodenal switch lowers both early and late phases of glucose, insulin and proinsulin responses after meal. Obes Surg 20(5):549–558PubMedCrossRef
Metadaten
Titel
Response to glucose tolerance testing and solid high carbohydrate challenge: comparison between Roux-en-Y gastric bypass, vertical sleeve gastrectomy, and duodenal switch
verfasst von
Mitchell S. Roslin
Yuriy Dudiy
Andrew Brownlee
Joanne Weiskopf
Paresh Shah
Publikationsdatum
01.01.2014
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 1/2014
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-013-3176-0

Weitere Artikel der Ausgabe 1/2014

Surgical Endoscopy 1/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.